Stocks

The table gives an overview of all stocks, alphabetically sorted.
 I-tech ITECH Mar 3, 2021 74.60 +1.08   
 I.A.R Systems Group B IARB Mar 3, 2021 128.00 -1.84   
 iApotek IAPO Mar 3, 2021 1.55 +3.32   
 ICA Gruppen ICA Mar 3, 2021 402.90 -0.20   
 Ice Group ICEGRO Mar 3, 2021 19.50 0.00   
 Iconovo ICO Mar 3, 2021 56.80 +1.07   
 IDEX Biometrics IDEXO Mar 3, 2021 3.09 -3.29   
 IDL Biotech IDL Mar 3, 2021 1.68 0.00   
 Idogen IDOGEN Mar 3, 2021 3.48 -0.57   
 Igrene ABI Mar 3, 2021 0.91 +0.89   
 Image Systems IS Mar 3, 2021 1.28 +1.59   
 IMINT Image Intelligence IMINT Mar 3, 2021 24.30 +1.25   
 Immunicum IMMU Mar 3, 2021 6.96 -1.56   
 Immunovia IMMNOV Mar 3, 2021 121.00 -2.10   
 Impact Coatings IMPC Mar 3, 2021 26.05 -2.07   
 Implantica IMPASDB Mar 3, 2021 140.00 -2.30   
 Implementa Sol B IMSOLB Mar 3, 2021 0.52 -2.61   
 InCoax INCOAX Mar 3, 2021 6.22 +0.97   
 InDex Pharmaceuticals Holding INDEX Mar 3, 2021 1.65 -1.79   
 Industrial Solar ISHE Mar 3, 2021 5.80 -3.33   
 Industrivärden A INDUA Mar 3, 2021 310.60 +0.39   
 Industrivärden C INDUC Mar 3, 2021 292.50 +0.17   
 Indutrade INDT Mar 3, 2021 203.00 +1.96   
 Infant Bacterial Therapeutics B IBTB Mar 3, 2021 108.40 -2.69   
 Infracom INFRA Mar 3, 2021 19.70 -0.76   
 Infrea INFREA Mar 3, 2021 31.30 -0.32   
 Infront INFROO Mar 3, 2021 29.90 0.00   
 Inhalation Sciences ISAB Mar 3, 2021 9.74 -1.62   
 Inission B INISSB Mar 3, 2021 115.50 -1.70   
 Initiator Pharma INIT Mar 3, 2021 5.58 +10.71   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK